International Research in Infectious Diseases, including AIDS (R01)

PA-17-142
International Research in Infectious Diseases, including AIDS (R01)
Department of Health and Human Services
National Institutes of Health

Research Objectives and Scope

Studies may be proposed on any aspect of infectious disease research (except clinical trials), including but not limited to: the epidemiology, natural history, pathogenesis, immunopathogenesis of infectious diseases; epidemiologic studies to define the incidence, clinical presentations, and outcomes of diseases; identification of resistance mechanisms and patterns; characterization of susceptible cohorts for a particular pathogen; pilot and feasibility studies in preparation for larger studies. NOTE: HIV/AIDS studies must address NIAID priorities described at http://www.niaid.nih.gov/about/division-aids-overview

Collaborative projects involving investigators and institutions from international sites and the U.S. are particularly encouraged; however, a U.S. partner is not required. NIH supports a number of international research programs on infectious diseases, including HIV/AIDS. For NIAID, these include the International Centers of Excellence in Research (ICERs), International Collaborations in Infectious Disease Research (ICIDRs), the Tropical Medicine Research Centers (TMRCs), the Centers of Excellence for Influenza Research and Surveillance (CEIRS), the International Centers of Excellence for Malaria Research (ICEMRS), the Tuberculosis Research Unit, the HIV Vaccine Trials Network (HVTN), the HIV Prevention Trials Network (HPTN),  International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT), AIDS Clinical Trials Group (ACTG), Microbicide Trials Network (MTN), the International Epidemiologic Database to Evaluate AIDS (IeDEA), and the Centers for AIDS Research (CFAR).

This International Research in Infectious Diseases including AIDS (IRIDA) Program is intended to extend these programs by expanding the breadth of research supported at international sites and by providing support to new researchers. Applications are particularly encouraged from institutions in eligible countries where NIH has significant investments through extramural research grants, cooperative agreements or contracts or through NIH intramural programs. Current NIH or NIAID funding is not a requirement.

Applicants are strongly encouraged to establish multi-institutional collaborations and to include activities that involve the transfer of technologies and research methods, sharing of core resources including the administration of research grant programs, and expansion of linkages to other sites via attendance at national and international meetings and other methods of communication.

Note: Clinical trials will not be supported. When non-interventional clinical studies using human subjects are an element of the research proposed, NIAID policy requires that studies be monitored commensurate with the degree of potential risk to study subjects and the complexity of the study. Guidance regarding policies and standard procedures for conducting NIAID-funded and/or -sponsored clinical research can be found at the following link: https://www.niaid.nih.gov/research/dmid-clinical-research-policies or https://www.niaid.nih.gov/research/daids-clinical-research-policies-standard-procedures.

Note: Select Agents Research will not be supported. Select Agents are biological agents or toxins listed in 42 CFR Part 737 CFR Part 331 and 9 CFR Part 121, or the HHS and USDA Select Agents and Toxins List.

General Information

Document Type: Grants Notice
Funding Opportunity Number: PA-17-142
Funding Opportunity Title: International Research in Infectious Diseases, including AIDS (R01)
Opportunity Category: Discretionary
Opportunity Category Explanation:  
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:  
Expected Number of Awards:  
CFDA Number(s): 93.855 — Allergy and Infectious Diseases Research
93.856 — Microbiology and Infectious Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Jan 30, 2017
Last Updated Date: Feb 01, 2017
Original Closing Date for Applications: Aug 22, 2019  
Current Closing Date for Applications: Feb 01, 2017  
Archive Date: Feb 02, 2017
Estimated Total Program Funding:  
Award Ceiling:  
Award Floor:  
Eligibility
Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations); Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. See Funding Opportunity for Eligibility Details
Additional Information
Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) encourages applications from organizations/institutions in eligible foreign countries that propose research related to infectious diseases that are of interest/importance to that country.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-17-142.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Department of Defense Amyotrophic Lateral Sclerosis Research Program

Defense Health Program
Department of Defense Amyotrophic Lateral Sclerosis Research Program
Funding Opportunities for Fiscal Year 2017 (FY17)

Source:  http://cdmrp.army.mil/pubs/press/2017/17alsrppreann

FY17 ALSRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on the Grants.gov website in March 2017. Pre-application and application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the Government, and funding of research projects received in response to these program announcements is contingent on the availability of Federal funds appropriated for the ALSRP.

As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency (DHA), J9 Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).

Award Mechanisms: The following mechanisms are planned for release:

Award Mechanism Eligibility Key Mechanism Elements Funding
Therapeutic Development Award Independent investigators at all academic levels
  • Pre-application is required; full application submission is by invitation only
  • Supports post-discovery, preclinical development of therapeutics for ALS
  • Preliminary data, including identify and purity of an identified bioactive compound(s), are required
  • Types of efforts that will be supported include:
    • Validation of lead pharmacological agents up to IND submission
    • Optimization of potency and pharmacology, studies of formulation, stability and production methods based on Good Manufacturing Practices
  • Collaboration with industry is encouraged
  • Clinical trials are not allowed
  • Does not support screening or development of screens or models
  • Maximum funding of $1,000,000 for direct costs (plus indirect costs)
  • Maximum period of performance is 2 years
Therapeutic Idea Award Independent investigators at all academic levels
  • Pre-application is required; full application submission is by invitation only.
  • Supports hypothesis-driven drug discovery efforts focused on ALS therapeutics
  • Preliminary data are not required
  • Types of efforts that will be supported include:
    • Novel exploitation of pathways known to be relevant to ALS for the purpose of improving treatment and/or advancing a novel treatment modality
    • Development, validation and use of novel high-throughput screens and model systems based on novel targets or innovative drug systems
    • Development of methods for measuring engagement of mechanistic targets by drug candidates
  • Innovation in technologies and techniques is an important criteria for application evaluation
  • Characterization of mechanisms for the purpose of identifying new targets is outside of the scope of this announcement
  • Maximum funding of $500,000 for direct costs (plus indirect costs)
  • Maximum period of performance is 2 years

Submission deadlines are not available until the Program Announcements are released. A pre-application is required and must be submitted through the CDMRP electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.

Full applications must be submitted through the federal government’s single-entry portal, Grants.gov. All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from Grants.gov. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the ALSRP or other CDMRP administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

Point of Contact:

CDMRP Public Affairs
301-619-9783
usarmy.detrick.medcom-cdmrp.mbx.cdmrp-public-affairs@mail.mil

Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (U01)

PAR-16-105
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (U01)
Department of Health and Human Services
National Institutes of Health

Purpose

The purpose of this funding opportunity announcement (FOA) is to encourage investigator-initiated research efforts aimed at the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. Tissue-engineered in vitro and ex vivo systems that reflect the pathology and physiology of human disease are needed within the existing continuum of cancer models as new tools for studying cancer biology. Complementary implementation of these tools with existing cancer models is envisioned to ultimately lead to advances in cancer prevention, early detection of aggressive cancer, diagnosis and treatment. To date, only a handful of validated, biologically relevant tissue-engineered technologies exist for addressing specific cancer research questions. Recent technological advances in biomimetic tissue-engineered systems for the purposes of regenerative medicine could allow for new, innovative applications to cancer research. This FOA will support multidisciplinary research projects, and the funded investigators will collectively establish and participate in the Cancer Tissue Engineering Collaborative (TEC) Research Program. Projects will focus on the development and characterization of in vitro systems using tissue-engineered technologies that mimic tumor biology to elucidate specific cancer phenomena that are otherwise difficult to examine in vivo.

This FOA is intended to encourage collaborative, multidisciplinary projects that engage the fields of cancer research with regenerative medicine, tissue engineering, biomaterials, and bioengineering. It is also expected to catalyze the advancement of innovative, well characterized in vitro and ex vivo systems available for cancer research, expand the breadth of these systems to several cancer types, and promote the exploration of cancer phenomena with biomimetic tissue-engineered systems beyond commonly studied areas such as cell migration and angiogenesis. Applicants are encouraged to leverage existing resources, such as in vivo models, imaging techniques, or computational models.

Background

Biomimetic Tissue-Engineered Technologies

Overview. Biomimetic tissue-engineered technologies combine information from the study of tissue structure and function with engineering, materials science, physics, chemistry, mathematics, and imaging to generate reproducible tissue in vitro that mimics three-dimensional (3D) in vivo tissue. When functionally characterized, the added control and reproducibility of tissue-engineered technologies can provide an enhanced understanding of cell and tissue biology under normal and pathological conditions. Tissue-engineered technologies have played a key role in advancing regenerative medicine over the past two decades, leading to the fabrication of systems that mimic components of several tissue types. New advances in biomaterials, engineering technologies, and stem cell engineering have greatly facilitated the engineering of tissues for in vitro applications, including studies of tissue morphogenesis, development, disease progression, molecular therapeutics, and drug toxicity screening in human tissues. As these technologies advance, opportunities exist for innovative ideas to leverage them in order to study other diseases including cancer and pre-malignant states.

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-16-105
Funding Opportunity Title: Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:  
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Education
Health
Category Explanation:  
Expected Number of Awards:  
CFDA Number(s): 93.393 — Cancer Cause and Prevention Research
93.394 — Cancer Detection and Diagnosis Research
93.395 — Cancer Treatment Research
93.396 — Cancer Biology Research
93.399 — Cancer Control
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Feb 19, 2016
Last Updated Date: Jan 27, 2017
Original Closing Date for Applications: Nov 30, 2018  
Current Closing Date for Applications: Jan 27, 2017  
Archive Date: Feb 26, 2017
Estimated Total Program Funding:  
Award Ceiling: $400,000
Award Floor:  
Eligibility
Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Private institutions of higher education
For profit organizations other than small businesses
County governments
State governments
Small businesses
Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Independent school districts
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
City or township governments
Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Additional Information
Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology will be essential for generating novel experimental models that mimic cancer pathophysiology. The projects supported by this FOA will establish and collectively participate in the Cancer Tissue Engineering Collaborative (TEC) Research Program.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-16-105.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R03)

PA-17-134
Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R03)
Department of Health and Human Services
National Institutes of Health

Research Objectives

This FOA seeks to expand knowledge about the effects of public policies on health-related behaviors and outcomes associated with alcohol, marijuana, prescription drugs, opiates, tobacco, and other substances. Such knowledge can inform discussions and decisions about public policies that ultimately lead to improvements in public health and welfare. The specific objectives of this FOA are to support innovative research that: (a) identifies and quantifies the causal effects of public policies on alcohol-, marijuana-, and other substance-related behaviors and outcomes; (b) evaluates the effectiveness of policy measures in improving health through their effects on such behaviors and outcomes; (c) elucidates the behavioral linkages through which public policies affect intervening attitudes, behaviors, incentives, or other factors that ultimately affect health-related behaviors or outcomes; and (d) advances methods and measurement used in studying relationships between public policies and  alcohol-, marijuana-, and other substance-related behaviors and outcomes.

This FOA is intended to support innovative research that examines policies and policy effects that are not well understood; it is not intended to reinforce or add nuanced detail to extant knowledge about policies that have been studied extensively. Examples of well-researched topics that are not expected to be supported by this FOA are studies of the effects of alcohol excise taxes on alcohol consumption or related problems, and the effects of the minimum legal drinking age on similar outcomes. However, research on other policies that may affect underage drinking is still needed. Studies that make use of policy information provided in NIAAA’s Alcohol Policy Information System (http://alcoholpolicy.niaaa.nih.gov) and/or the Prescription Drug Abuse Policy System (http://pdaps.org) developed by NIDA are particularly encouraged.

Applications that propose to conduct health economics research should be consistent with current NIH priorities for health economics research. See https://grants.nih.gov/grants/guide/notice-files/NOT-OD-16-025.html for more details.

Grants under this announcement may not be used to promote enactment, adoption, or repeal of any specific public policies. Applicants are advised to review and adhere to all anti-lobbying provisions that apply to Federal research grants.

Document Type: Grants Notice
Funding Opportunity Number: PA-17-134
Funding Opportunity Title: Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R03)
Opportunity Category: Discretionary
Opportunity Category Explanation:  
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:  
Expected Number of Awards:  
CFDA Number(s): 93.273 — Alcohol Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jan 25, 2017
Last Updated Date: Jan 25, 2017
Original Closing Date for Applications: May 07, 2020  
Current Closing Date for Applications: May 07, 2020  
Archive Date: Jun 07, 2020
Estimated Total Program Funding:  
Award Ceiling: $50,000
Award Floor:  
Eligibility
Eligible Applicants: Small businesses
County governments
State governments
For profit organizations other than small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Public housing authorities/Indian housing authorities
Private institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Independent school districts
Native American tribal governments (Federally recognized)
City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Additional Information
Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) encourages applications to conduct research on the effects of public policies on health-related behaviors and outcomes associated with alcohol, marijuana, and other substances. The purpose of the FOA is to advance understanding of how public policy may serve as a tool for improving public health and welfare through its effects on behaviors and outcomes pertaining to alcohol and other drugs. This FOA is intended to support innovative research to examine policy effects that have the potential to lead to meaningful changes in public health. Research projects that may be supported by this FOA include, but are not necessarily limited to: causal analyses of the effects of one or multiple public policies; evaluations of the effectiveness of specific public policies as tools for improving public health through their effects on alcohol-, marijuana-, and other substance-related behaviors and outcomes; and research to advance methods and measurement used in studying relationships between public policies and alcohol-, marijuana-, and other substance-related behaviors and outcomes. The R03 Small Research Grant Program supports discrete, well-defined projects that realistically can be completed in two years and that require limited levels of funding. This program supports different types of projects including (but not limited to) pilot or feasibility studies; secondary analysis of existing data; small, self-contained research projects; and development of research methodology.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PA-17-134.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Cancer Immune Monitoring and Analysis Centers (U24)

RFA-CA-17-005
Cancer Immune Monitoring and Analysis Centers (U24)
Department of Health and Human Services
National Institutes of Health

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-CA-17-005
Funding Opportunity Title: Cancer Immune Monitoring and Analysis Centers (U24)
Opportunity Category: Discretionary
Opportunity Category Explanation:  
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Education
Health
Category Explanation:  
Expected Number of Awards:  
CFDA Number(s): 93.394 — Cancer Detection and Diagnosis Research
93.395 — Cancer Treatment Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Dec 16, 2016
Last Updated Date: Jan 25, 2017
Original Closing Date for Applications: Mar 03, 2017  
Current Closing Date for Applications: Mar 17, 2017  
Archive Date: Apr 16, 2017
Estimated Total Program Funding:  
Award Ceiling: $1,400,000
Award Floor:  
Eligibility
Eligible Applicants: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
State governments
City or township governments
Private institutions of higher education
For profit organizations other than small businesses
Independent school districts
Native American tribal organizations (other than Federally recognized tribal governments)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
County governments
Public and State controlled institutions of higher education
Public housing authorities/Indian housing authorities
Small businesses
Native American tribal governments (Federally recognized)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Additional Information
Agency Name: National Institutes of Health
Description: This National Cancer Institute (NCI) funding opportunity announcement (FOA) solicits applications for multidisciplinary Cancer Immune Monitoring and Analysis Centers (CIMACs) that will serve as the main units of the Network for correlative studies in clinical trials involving immunotherapy. The Network will encompass two to three CIMACs (to be supported by this FOA) and a single Cancer Immunologic Data Commons (CIDC) (to be supported by the companion FOA, RFA-CA-17-006) forming a CIMACs-CIDC Network.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-17-005.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Validation of survey questions to distinguish type 1 and type 2 diabetes among adults with diabetes

RFA-DP-17-002
Validation of survey questions to distinguish type 1 and type 2 diabetes among adults with diabetes
Department of Health and Human Services
Centers for Disease Control and Prevention – ERA

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DP-17-002
Funding Opportunity Title: Validation of survey questions to distinguish type 1 and type 2 diabetes among adults with diabetes
Opportunity Category: Discretionary
Opportunity Category Explanation:  
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:  
Expected Number of Awards: 1
CFDA Number(s): 93.068 — Chronic Diseases: Research, Control, and Prevention
Cost Sharing or Matching Requirement: No
Version: Synopsis 7
Posted Date: Dec 20, 2016
Last Updated Date: Jan 25, 2017
Original Closing Date for Applications: Feb 21, 2017  Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Current Closing Date for Applications: Feb 21, 2017  Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Archive Date: Mar 23, 2017
Estimated Total Program Funding: $1,000,000
Award Ceiling: $500,000
Award Floor: $100,000
Eligibility
Eligible Applicants: Native American tribal organizations (other than Federally recognized tribal governments)
Independent school districts
State governments
City or township governments
Public housing authorities/Indian housing authorities
For profit organizations other than small businesses
Small businesses
Special district governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Private institutions of higher education
Native American tribal governments (Federally recognized)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Additional Information on Eligibility:  
Additional Information
Agency Name: Centers for Disease Control and Prevention – ERA
Description: Most survey-based prevalence estimates of type 1 diabetes among adults have been based on self-reported information about a young age at diagnosis (e.g., <30 years and <40 years) and insulin use within a year of diagnosis. However, this estimation approach misses type 1 diabetes in adults with older age of onset and may misclassify some cases of type 2 diabetes as type 1 if insulin use begins soon after diagnosis. The major goal of this project is to evaluate the validity of survey questions (or algorithms based on them) to distinguish between adults (aged ≥18 years of age) with type 1 and type 2 diabetes in a representative sample of adult diabetic patients in a diabetes patient registry or database. Using a gold standard, validity will be assessed by examining the sensitivity, specificity, and positive predictive value of algorithms to identify type of diabetes across demographic strata such as age, sex, and race. A secondary goal is to validate definitions of type of diabetes using electronic health records.
Link to Additional Information:  
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Marcella Law mah7@cdc.gov

Grants Policy

Using Evidence Informed Interventions to Improve Health Outcomes among People Living with HIV –Technical Assistance

HRSA-17-044
Using Evidence Informed Interventions to Improve Health Outcomes among People Living with HIV –Technical Assistance
Department of Health and Human Services
Health Resources and Services Administration

General Information

Document Type: Grants Notice
Funding Opportunity Number: HRSA-17-044
Funding Opportunity Title: Using Evidence Informed Interventions to Improve Health Outcomes among People Living with HIV –Technical Assistance
Opportunity Category: Discretionary
Opportunity Category Explanation:  
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation: https://grants.hrsa.gov/2010/Web2External/Interface/FundingCycle/ExternalView.aspx?fCycleID=a20ab976-e5bd-4425-9c54-b7a3709a0d09
Expected Number of Awards: 1
CFDA Number(s): 93.928 — Special Projects of National Significance
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Dec 15, 2016
Last Updated Date: Dec 15, 2016
Original Closing Date for Applications: Mar 01, 2017  
Current Closing Date for Applications: Mar 01, 2017  
Archive Date: Apr 30, 2017
Estimated Total Program Funding: $5,325,000
Award Ceiling: $0
Award Floor: $0
Eligibility
Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Eligible applicants include entities eligible for funding under RWHAP Parts A, B, C and D.  These include, but are not limited to: public and nonprofit private entities involved in addressing HIV/AIDS related issues at the regional or national level; state and local governments; academic institutions; local health departments; nonprofit hospitals and outpatient clinics; community health centers receiving support under Section 330 of the PHS Act; Federally Qualified Health Centers as described in Title XIX, Section 1905 of the Social Security Act; faith-based and community-based organizations; and Indian Tribes or Tribal organizations with or without federal recognition. Foreign entities are not eligible for these HRSA awards.
Additional Information
Agency Name: Health Resources and Services Administration
Description: This announcement solicits applications for fiscal year (FY) 2017 to support a single organization that will serve as the Evidence-Informed Interventions Coordinating Center for Technical Assistance (E2i CCTA) for a new initiative entitled Using Evidence-Informed Interventions to Improve Health Outcomes among People Living with HIV (PLWH).  The goal of this four-year cooperative agreement is to identify and provide support for the implementation of evidence-informed interventions to reduce HIV-related health disparities and improve health outcomes, including increasing retention in care, improving treatment adherence, and improving viral suppression for PLWH.  The project will focus on implementing effective and culturally appropriate evidence-informed interventions that will be tailored to meet the needs of the target populations, using the framework of implementation science, and assessing and adapting the interventions at interim intervals throughout the project period.  The evidence-informed interventions will be in four focus areas:
Link to Additional Information:  
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Department of Health and Human Services, Health Resources and Services Administration SGagne@hrsa.gov

Contact Stacy Cohen Gagne at (301)443-3259 or email SGagne@hrsa.gov

Identify and Characterize Potential Environmental Risk Factors for Amyotrophic Lateral Sclerosis (ALS) and Evaluate Their Impact on ALS Disease Incidence and Progression

RFA-TS-17-001
Identify and Characterize Potential Environmental Risk Factors for Amyotrophic Lateral Sclerosis (ALS) and Evaluate Their Impact on ALS Disease Incidence and Progression

Department of Health and Human Services
Centers for Disease Control and Prevention – ERA

General Information

Document Type: Grants Notice
Opportunity Number: RFA-TS-17-001
Opportunity Title: Identify and Characterize Potential Environmental Risk Factors for Amyotrophic Lateral Sclerosis (ALS) and Evaluate Their Impact on ALS Disease Incidence and Progression
Opportunity Category: Discretionary
Opportunity Category Explanation:  
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:  
Expected Number of Awards: 5
CFDA Number(s): 93.061 — Innovations in Applied Public Health Research
Cost Sharing or Matching Requirement: No
Version: Forecast 1
Posted Date: Dec 22, 2016
Last Updated Date: Dec 22, 2016
Estimated Synopsis Post Date: Dec 30, 2016
Estimated Application Due Date: Mar 31, 2017  Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
Estimated Award Date: Sep 29, 2017
Estimated Project Start Date: Sep 30, 2017
Fiscal Year: 2017
Archive Date: Apr 30, 2017
Estimated Total Program Funding: $7,500,000
Award Ceiling: $500,000
Award Floor: $350,000
Eligibility
Eligible Applicants: For profit organizations other than small businesses
Public housing authorities/Indian housing authorities
Public and State controlled institutions of higher education
County governments
Native American tribal organizations (other than Federally recognized tribal governments)
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal governments (Federally recognized)
Special district governments
Private institutions of higher education
State governments
Independent school districts
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Additional Information on Eligibility: NONE
Additional Information
Agency Name: Centers for Disease Control and Prevention – ERA
Description: The Agency for Toxic Substances and Disease Registry (ATSDR) is soliciting investigator-initiated research that will identify and characterize environmental toxicants in human biological samples that may be potential environmental risk factors for Amyotrophic Lateral Sclerosis (ALS). Applications are also sought that will evaluate the impact of environmental toxicants on the development and progression of ALS, including gene-environment interactions. Information gleaned from this investigator-initiated research will provide a greater understanding of the possible link between exposures to environmental toxicants and the etiology of ALS.
Link to Additional Information:  
Grantor Contact Information: Marcienne Wright
(770) 488-4850

lxv8@cdc.gov

Jointly Sponsored Ruth L. Kirschstein National Research Service Award for Institutional Predoctoral Training Programs in the Neurosciences (T32)

PAR-17-096
Jointly Sponsored Ruth L. Kirschstein National Research Service Award for Institutional Predoctoral Training Programs in the Neurosciences (T32)
Department of Health and Human Services
National Institutes of Health

Program Objectives

The purpose of the Jointly Sponsored Predoctoral Training Program in the Neurosciences (JSPTPN) is to provide strong, broad neuroscience training that will enable students to become successful research scientists at a time when the field is advancing at an astonishing pace. Neuroscience research increasingly requires investigators who can cross boundaries, draw on knowledge and approaches from various disciplines and levels of analysis, and apply this breadth of knowledge in novel ways to yield new discoveries about the nervous system. Moreover, the ability to conduct impactful neuroscience research requires strong foundational skills in experimental design, statistical methodology and quantitative reasoning related to study design, analysis and interpretation.

Breakthroughs in neuroscience have come, and will continue to come, not only from a deep and broad understanding of the nervous system, but also from an understanding of biological systems not historically associated with neuroscience.  For example, blood brain barrier function is now known to be heavily dependent on the multidrug resistance transporter, inflammatory responses are key components of many neurological disorders, and metabolic processes historically associated with biology or diseases outside the nervous system are now known to play a role in both normal brain function and neurobiological disorders. To achieve the goals of the JSPTPN, students should therefore be exposed to a broad spectrum of relevant science. In addition, the training supported by the JSPTPN must be grounded in principles of rigorous experimental design, an understanding of the critical need for, and proper use of, statistics, and quantitative literacy.

Broad-based research training. The JSPTPN supports a program of broad-based education and research experience during the first two years of graduate training. As such, training programs supported by a JSPTPN training grant must have a comprehensive, two-year training plan.

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-17-096
Funding Opportunity Title: Jointly Sponsored Ruth L. Kirschstein National Research Service Award for Institutional Predoctoral Training Programs in the Neurosciences (T32)
Opportunity Category: Discretionary
Opportunity Category Explanation:  
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:  
Expected Number of Awards:  
CFDA Number(s): 93.242 — Mental Health Research Grants
93.279 — Drug Abuse and Addiction Research Programs
93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders
93.859 — Biomedical Research and Research Training
93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Dec 22, 2016
Last Updated Date: Dec 22, 2016
Original Closing Date for Applications: May 25, 2019  
Current Closing Date for Applications: May 25, 2019  
Archive Date: Jun 25, 2019
Estimated Total Program Funding:  
Award Ceiling:  
Award Floor:  
Eligibility
Eligible Applicants: Native American tribal governments (Federally recognized)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Special district governments
Public housing authorities/Indian housing authorities
For profit organizations other than small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Private institutions of higher education
County governments
Public and State controlled institutions of higher education
Independent school districts
State governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Additional Information
Agency Name: National Institutes of Health
Description: The Jointly Sponsored NIH Predoctoral Training Program in the Neurosciences (JSPTPN) is an institutional program that supports broad and fundamental research training in the neurosciences. In addition to a broad education in the neurosciences, a key component will be a curriculum that provides a strong foundation in experimental design, statistical methodology and quantitative reasoning. . JSPTPN programs are intended to be two years in duration, and students may only be appointed to this training grant during the first 2 years of their graduate research training. The primary objective is to prepare individuals for careers in neuroscience that will have a significant impact on our understanding of nervous system function and the health-related research needs of the nation.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-17-096.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Children with Special Health Care Needs Research Network (CSHCN-RN)

HRSA-17-060
Children with Special Health Care Needs Research Network (CSHCN-RN)
Department of Health and Human Services
Health Resources and Services Administration

General Information

Document Type: Grants Notice
Opportunity Number: HRSA-17-060
Opportunity Title: Children with Special Health Care Needs Research Network (CSHCN-RN)
Opportunity Category: Discretionary
Opportunity Category Explanation:  
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:  
Expected Number of Awards: 1
CFDA Number(s): 93.110 — Maternal and Child Health Federal Consolidated Programs
Cost Sharing or Matching Requirement: No
Version: Forecast 1
Posted Date: Dec 22, 2016
Last Updated Date: Dec 22, 2016
Estimated Synopsis Post Date: Jan 16, 2017
Estimated Application Due Date: Mar 16, 2017  
Estimated Award Date:  
Estimated Project Start Date:  
Fiscal Year: 2017
Archive Date:  
Estimated Total Program Funding:  
Award Ceiling:  
Award Floor:  
Eligibility
Eligible Applicants: City or township governments
County governments
Native American tribal governments (Federally recognized)
Additional Information on Eligibility:  
Additional Information
Agency Name: Health Resources and Services Administration
Description: The goal of the Children with Special Health Care Needs Research Network (CSHCN-RN) is to establish an interdisciplinary, multi-site, collaborative research network that will lead, promote, and coordinate national research activities aimed at building the evidence base for the effectiveness of the Core System Outcomes  for children with special health care needs (CSHCN) in achieving positive health outcomes.  Specifically, the Network will conduct collaborative research studies focused on: (1) improving family-professional partnerships for shared decision making (family engagement, shared decision making); (2) the delivery of comprehensive care within a patient/family-centered medical home (care coordination, family-centered care, co-management of care); (3) the role of health insurance (adequacy of insurance, gaps in coverage, managed care) on access to needed care and health and functional outcomes for CSHCN; and (4) containing cost of care and services by determining and validating the effectiveness of a framework for health care financing and provider  reimbursement for care of CSHCN within the family-centered medical home.
Link to Additional Information:  
Grantor Contact Information: Robin Harwood
301-443-3888

rharwood@hrsa.gov